Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

CSE:PHRM - Post Discussion

View:
Post by Godfather on Apr 26, 2022 4:03pm

Good close

Barring a market meltdown, it's set up well for the rest of the week. Chart is looking solid.
Comment by GustheGreek on Apr 29, 2022 11:12am
It sucks shyt!!! Their market cap dropped almost 90% in 9 months. Horrible management!!!
Comment by Iamjaygee on Apr 29, 2022 2:02pm
What's wrong with the management? They've done nothing but follow through with their plans, and consistently put out good news. Bio stocks are a waiting game. That pump we got this week is nothing compared to what we'll get if phase 3 gets approved.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities